EichorEICHOR
Location: Leuven Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Leuven

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Long-term Longitudinal Imaging of Presynaptic Terminals in PD
NA · UZ Leuven · Universitaire Ziekenhuizen KU Leuven · NCT06875765
A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · Universitair Ziekenhuis Leuven · Janssen Research & Development, LLC · NCT06449651
Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 0560001 · Sanofi · NCT06867094
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · UZ Leuven · Pfizer · NCT07028853
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · UZ Leuven - Centrum voor Moleculaire en Vasculaire Biologie · CSL Behring · NCT07080905
Performance After Cardiac Ablation in Endurance Athletes for Atrial Fibrillation
NA · UZ Leuven · University Hospital of Leuven Leuven · NCT07726056
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · UZ Leuven · University of Birmingham · NCT05991388
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · UZ Leuven · Princess Maxima Center for Pediatric Oncology · NCT05327894
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · UZ Leuven-Hematology ( Site 0200) · Merck Sharp & Dohme LLC · NCT06136559
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Phase 2 · UZ Leuven · Boehringer Ingelheim · NCT06636656
Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)
Phase 3 · Katholieke Universiteit te Leuven · NTC srl · NCT07465705
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg · Miltenyi Biomedicine GmbH · NCT04844866
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site BE32003 · Astellas Pharma Global Development, Inc. · NCT05970172
Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus
NA · Uz Leuven · Universitaire Ziekenhuizen KU Leuven · NCT06767631
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Universitair Ziekenhuis Leuven /ID# 277350 · AbbVie · NCT06682988
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · UZ Leuven · Pfizer · NCT07073820
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · UZ Leuven · Boehringer Ingelheim · NCT07355296
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Investigational Site Number : 0560001 · Sanofi · NCT07190196
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · UZ Leuven Gasthuisberg · Hoffmann-La Roche · NCT06793215
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Phase 3 · Universitair Ziekenhuis Leuven · Lakefront Biotherapeutics NV · NCT06652633
Conservative Endometrioma Surgery
NA · UZLeuven · Universitaire Ziekenhuizen KU Leuven · NCT04151433
The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · University Hospitals Leuven · University of Oxford · NCT05169333
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Universitair Ziekenhuis Leuven - Campus Gasthuisberg · Amgen · NCT07037433
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · UZ Leuven · Eli Lilly and Company · NCT07483099
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · UZ Leuven ( Site 0401) · Merck Sharp & Dohme LLC · NCT07216703
A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pou
Phase 3 · UZ Leuven · Takeda · NCT06443502
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · UZ Leuven · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · UZ Leuven Gasthuisberg · Alimentiv Inc. · NCT07363044
Look up another city
Look up another condition